Nucor Corporation NUE
Verdict: Sell. Fair value $168 against a price of $169 on 6 Jan 2026.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. Revenue declined 26% from its 2022 peak to 2024 ($41.51B to $30.73B). Over the same period, Net....
Main risks
- Severe Margin Compression & Negative FCF: TTM Free Cash Flow is negative ($-0.33B) amid heavy CapEx ($3.5B) while operating margins have collapsed, indicating high cash burn during a downturn.
- Negative Returns on Incremental Capital (ROIIC): A heavily proxied but directionally alarming ROIIC of -67.5% suggests that significant recent investments are destroying value as profits fall.
- Sharp Cyclical Downturn: Revenue has declined 26% from its 2022 peak, and profitability has fallen even faster, highlighting the business's high sensitivity to the economic cycle.
- Revenue declined 26% from its 2022 peak to 2024 ($41.51B to $30.73B). Over the same period, Net...
- Intense competitive environment
- Revenue declined 26% from its 2022 peak to 2024 ($41.51B to $30.73B). Over the same period, Net Income plummeted 73% ($7.61B to $2.03B), indicating severe margin pressure and high operating leverage, which is a significant business risk.